ArticleTranslational oncology2018

Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer.

Ning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.